Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won’t work as expected without them. To learn more about cookies and their benefits, please view our cookies policy. You could also decide what kind of cookie the website could use or not use on our cookies settings page.
By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy unless you have disabled them.

Help menu :

  1. Sanofi Worldwide |
     
  2. Our UK Websites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Site map |
  6. Help
  1. RSS
  2. Font size

    Reduce font size Increase font size  
 
 

Our Activities

Content :

Renal

February 11, 2015

Our commitment to research in the renal field ensures support of a variety of studies to develop further understanding of the disease processes and their treatment.

 
Renal

Nearly 50,000 people in the UK suffer from end-stage renal disease (ESRD) and depend on haemodialysis to replace their kidney function. Integrated within the Sanofi Group in the UK and Ireland since January 2012, Genzyme's renal franchise now operates as a Sanofi business unit.

Sanofi offers the information on this website for general educational and informational purposes only. Product information is specific to the UK and is not intended to replace the advice of a healthcare professional. For information on Sanofi's product portfolio in the UK please visit the Our Products section of this website.

 

Module :

Corporate Information

Corporate Information

 

Sanofi in the UK

Find out more about Sanofi UK's business units and locations, our investment in research and development, and our product pipeline